Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
May 22, 2024 06:00 ET
|
Mesa Laboratories, Inc.
LAKEWOOD, Colo., May 22, 2024 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (“Mesa”) (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending...
BlackLine, Inc. Announces Upsize and Pricing of Offering of $600,000,000 of Convertible Senior Notes
May 22, 2024 05:59 ET
|
BlackLine, Inc.
LOS ANGELES, May 22, 2024 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced the pricing of $600,000,000 aggregate principal amount of 1.00% convertible senior notes due 2029 (the...
VEON Receives Nasdaq Notice on Delayed Filing, Confirms Ongoing Effort to Address Auditor Appointment
May 22, 2024 05:30 ET
|
VEON Ltd.
Amsterdam, 22 May 2024 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, (“VEON” or the “Company”),...
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
May 22, 2024 04:00 ET
|
Rhythm Pharmaceuticals, Inc.
BOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their...
NANOBIOTIX fait le point sur ses résultats financiers et opérationnels du premier trimestre 2024
May 22, 2024 02:00 ET
|
Nanobiotix S.A.
PARIS et CAMBRIDGE, Mass., 22 mai 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique...
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
May 22, 2024 02:00 ET
|
Nanobiotix S.A.
PARIS and CAMBRIDGE, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based...
Arbutus to Present Imdusiran Data at EASL Congress 2024
May 22, 2024 02:00 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
GOGL – First Quarter 2024 Results
May 22, 2024 02:00 ET
|
Golden Ocean Group Limited
Golden Ocean Group Limited (NASDAQ/OSE: GOGL) (the “Company” or “Golden Ocean”), the world's largest listed owner of large size dry bulk vessels, today announced its unaudited results for the...
LifeStance Health Group Announces Pricing of Secondary Public Offering
May 21, 2024 23:43 ET
|
LifeStance Health, Inc.
SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person...
萬利能源國際有限公司在非洲毛里求斯順利完成其首次燃油船舶供應服務
May 21, 2024 21:00 ET
|
CBL International Limited
香港, May 22, 2024 (GLOBE NEWSWIRE) -- 萬利集團（以下簡稱「集團」）（美國納斯達克交易所代碼：BANL）子公司，亞太地區知名的船舶燃油供應公司，萬利能源國際有限公司宣布已於5月13日順利完成其首次在非洲毛里求斯路易港進行的燃油船舶供應服務。這標誌著集團首次踏足非洲大陸，並展示了我們拓展供船舶燃油供應網路，持續擴大市場份額的決心。 ...